Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Ependymoma

Ependymoma

Part of Glioma

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Ependymoma

8 trials tracked for Ependymoma: 1 in phase 3 or 4.

8Trials tracked
1Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 1 Phase 2 4 Phase 1 2 Other / NA 1
  1. Phase 3 Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Completed
  2. Phase 2 Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial) Completed
  3. Phase 2 Carboplatin and Bevacizumab for Recurrent Ependymoma Completed
  4. Phase 2 A Study of Pemetrexed in Children With Recurrent Cancer Completed
  5. Phase 2 Proton Radiotherapy for Pediatric Brain Tumors Requiring Partial Brain Irradiation Completed
  6. Phase 1 HUMC 1612: Optune NovoTTF-200A System Completed
Show 2 more trials
  1. Phase 1 Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children Completed
  2. N/A Molecular-Guided Therapy for Childhood Cancer Completed

Showing the 8 most-cited and recently-updated of 8 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
CAR T-cell therapies targeting specific antigens show potential for treating pediatric CNS tumors
Oncology Sys. Review
CAR T-cell therapies targeting specific antigens show potential for treating pediatric CNS tumors New CAR T-cell therapies show promise for pediatric brain tumors
This narrative review synthesizes 18 studies, including preclinical and early-phase clinical trials, regarding CAR T-cell therapy for pediat…
CAR T-cell therapy is showing potential to shrink tumors and extend life in children with aggressive brain cancers like DIPG.
Frontiers Jul 26, 2026
Case report describes intracranial WHO Grade II ependymoma with rare lipomatous metaplasia
Oncology Sys. Review
Case report describes intracranial WHO Grade II ependymoma with rare lipomatous metaplasia Doctors report rare case of brain tumor containing fat tissue in young man
A case report and literature review describes a 28-year-old male with an incidentally discovered intracranial mass.
A rare brain tumor containing fat tissue was found in a young man, prompting doctors to review similar cases to help identify this unique va…
Frontiers Apr 2, 2026